Atossa Genetics vs Pharmicell Co., Ltd.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Pharmicell Co., Ltd. is the larger company by market value: $514 M against $26 M for Atossa Genetics, 20 times as much (market caps of Oct 14, 2026 for Atossa Genetics and Aug 1, 2026 for Pharmicell Co., Ltd.). Pharmicell Co., Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Side by side
| Measure | Atossa Genetics ATOS · #23,584 in the world | Pharmicell Co., Ltd. 005690.KS · #12,407 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇰🇷 South Korea |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | — |
| Size | ||
| Market cap | $26 M | $514 M |
| Net income | $-35 M | — |
| Valuation | ||
| Price to book | 0.7× | — |
| Free cash flow yield | -116.6% | — |
| Profitability | ||
| Return on equity | -62.7% | — |
| Altman Z-score zone | — | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Aug 2026 |
Questions and answers#
Which is bigger, Atossa Genetics or Pharmicell Co., Ltd.?
Pharmicell Co., Ltd. is the larger company by market value: $514 M against $26 M for Atossa Genetics, 20 times as much (market caps of Oct 14, 2026 for Atossa Genetics and Aug 1, 2026 for Pharmicell Co., Ltd.). Pharmicell Co., Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.